Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K.

PLoS Med. 2006 Sep;3(9):e360.

2.

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

Steel J.

BioDrugs. 2011 Oct 1;25(5):285-98. doi: 10.2165/11593870-000000000-00000. Review.

PMID:
21942913
3.

Development and application of avian influenza vaccines in China.

Chen H, Bu Z.

Curr Top Microbiol Immunol. 2009;333:153-62. doi: 10.1007/978-3-540-92165-3_7. Review.

PMID:
19768404
4.

H5N1 vaccines in humans.

Baz M, Luke CJ, Cheng X, Jin H, Subbarao K.

Virus Res. 2013 Dec 5;178(1):78-98. doi: 10.1016/j.virusres.2013.05.006. Epub 2013 May 28. Review.

5.

Live attenuated vaccines for pandemic influenza.

Chen GL, Subbarao K.

Curr Top Microbiol Immunol. 2009;333:109-32. doi: 10.1007/978-3-540-92165-3_5. Review.

PMID:
19768402
6.

Designing vaccines for pandemic influenza.

Horimoto T, Kawaoka Y.

Curr Top Microbiol Immunol. 2009;333:165-76. doi: 10.1007/978-3-540-92165-3_8. Review.

PMID:
19768405
7.

Vaccines for pandemic influenza.

Luke CJ, Subbarao K.

Emerg Infect Dis. 2006 Jan;12(1):66-72. Review.

8.

Vaccines for pandemic influenza: summary of recent clinical trials.

Keitel WA, Atmar RL.

Curr Top Microbiol Immunol. 2009;333:431-51. doi: 10.1007/978-3-540-92165-3_21. Review.

PMID:
19768418
9.

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.

Kiseleva I, Larionova N, Rudenko L.

Open Microbiol J. 2017 Nov 30;11:316-329. doi: 10.2174/1874285801711010316. eCollection 2017. Review.

10.

Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.

Zhang J.

Viruses. 2012 Nov 1;4(11):2711-35. doi: 10.3390/v4112711. Review.

11.

Attenuated influenza virus vaccines with modified NS1 proteins.

Richt JA, GarcĂ­a-Sastre A.

Curr Top Microbiol Immunol. 2009;333:177-95. doi: 10.1007/978-3-540-92165-3_9. Review.

PMID:
19768406
12.

H5N1 viruses and vaccines.

Subbarao K, Luke C.

PLoS Pathog. 2007 Mar;3(3):e40. Review. No abstract available.

13.

[Avian influenza vaccines].

Vasil'ev IuM.

Vopr Virusol. 2008 Nov-Dec;53(6):4-15. Review. Russian.

PMID:
19172900
14.

Reference viruses for seasonal and pandemic influenza vaccine preparation.

Wood JS, Robertson JS.

Influenza Other Respir Viruses. 2007 Jan;1(1):5-9. Review.

15.

Antigenic cross-reactivity among H5N1 viruses.

Boon AC, Webby RJ.

Curr Top Microbiol Immunol. 2009;333:25-40. doi: 10.1007/978-3-540-92165-3_2. Review.

PMID:
19768399
16.

Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam.

Le TH, Nguyen NT.

Clin Exp Vaccine Res. 2014 Jul;3(2):117-27. doi: 10.7774/cevr.2014.3.2.117. Epub 2014 Jun 20. Review.

17.

Vaccines for an influenza pandemic: scientific and political challenges.

Haaheim LR.

Influenza Other Respir Viruses. 2007 Mar;1(2):55-60. doi: 10.1111/j.1750-2659.2007.00011.x. Review.

18.

Animal models for evaluation of influenza vaccines.

Tripp RA, Tompkins SM.

Curr Top Microbiol Immunol. 2009;333:397-412. doi: 10.1007/978-3-540-92165-3_19. Review.

PMID:
19768416
19.

Temperature-sensitive bacterial pathogens generated by the substitution of essential genes from cold-loving bacteria: potential use as live vaccines.

Duplantis BN, Bosio CM, Nano FE.

J Mol Med (Berl). 2011 May;89(5):437-44. doi: 10.1007/s00109-010-0721-3. Epub 2011 Jan 13. Review.

PMID:
21229224

Supplemental Content

Support Center